DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

InterMune (NASDAQ: ITMN)

73.65 -0.13 (-0.18%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ITMN $73.65 -0.18%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.70
Previous Close $73.78
Daily Range $73.64 - $73.75
52-Week Range $10.95 - $73.79
Market Cap $8.0B
P/E Ratio -28.38
Dividend (Yield) $0.00 (0.0%)
Volume 2,254,493
Average Daily Volume 5,706,609
Current FY EPS -$2.72

Sector

Healthcare

Industry

Drugs

InterMune (ITMN) Description

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website: http://www.intermune.com/

News & Commentary

Up 35% on Buyout: InterMune inc Investor Key Takeaways

FDA's rejection of InterMune's Esbriet hurt investors, but Roche clearly thinks the drug will be approved.

10 Nasdaq stocks with returns of at least 240% in 2014

Is Roche At Risk Of Losing Its Way?

Roche's Cobas 6800/8800 Testing Systems Launched - Analyst Blog

Roche's Cobas 6800/8800 Testing Systems Launched - Analyst Blog

Buying Biotech

Notable ETF Outflow Detected - IWO, ITMN, PBYI, WEX

Merger Arbitrage Mondays - September 1, 2014

Will This Retail Stock Survive? (Podcast)

What You Need to Know About the Roche-InterMune Deal

Markets Reverse Early Morning Losses; Still Lower On The Day

Benzinga's Top Initiations

See More ITMN News...

ITMN's Top Competitors

ITMN $73.65 (-0.18%)
Current stock: ITMN
AMGN $137.97 (0.06%)
Current stock: AMGN
GILD $100.99 (-2.58%)
Current stock: GILD
BIIB $320.12 (-1.01%)
Current stock: BIIB